Medicines losing patent protection

MonthYear

October 2027

5 medicines lose their last listed patent or exclusivity in October 2027.

Oct 2Chlorhexidine Gluconatechlorhexidine gluconate · Sage Products Inc
Oct 16Xyzal Allergy 24HRlevocetirizine dihydrochloride · Chattem Inc dba Sanofi Consumer Healthcare
Oct 25Amitizalubiprostone · Sucampo Pharma Americas LLC
Oct 27Beleodaqbelinostat · Acrotech Biopharma Inc
Oct 30Bronchitolmannitol · Pharmaxis Europe Ltd

Dates are the patent and exclusivity end dates listed in the FDA's Orange Book, in its data up to October 9, 2026. Patents can be extended, challenged in court or settled, so a generic may come earlier, later or not at all. This is not legal or medical advice.

About the data·Privacy·Credits